FPS
UTMD icon

Fieldpoint Private Securities’s Utah Medical Products UTMD Stock Holding History

Fieldpoint Private Securities’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-103
Closed -$10K – 723
2019
Q3 		$10K Sell
103
-250
-71% -$23.2K ﹤0.01% 582
2019
Q2 		$34K Buy
+353
New +$29.7K 0.01% 464
2017
Q4 		– Sell
-372
Closed -$27K – 562
2017
Q3 		$27K Buy
+372
New +$26.8K 0.01% 480

Other funds holding UTMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fieldpoint Private Securities's UTMD Position: Q4 2019 in Review

Fieldpoint Private Securities sold out of Utah Medical Products (UTMD) in Q4 2019, closing a stake of 103 shares — an estimated $10K sold.

Fieldpoint Private Securities first reported a position in UTMD in Q3 2017 and held it in 3 quarters. The position peaked at $34K in Q2 2019. 96 funds tracked by Wall St. Rank hold UTMD as of Q4 2019.

  • Fieldpoint Private Securities reported no remaining Utah Medical Products position as of Q4 2019 after selling out during the quarter.
  • Fieldpoint Private Securities sold 103 Utah Medical Products shares in Q4 2019, an estimated $10K.
  • Fieldpoint Private Securities first reported a position in Utah Medical Products in Q3 2017 and held it in 3 quarters.
  • Fieldpoint Private Securities's Utah Medical Products position peaked at $34K in Q2 2019.
  • 96 funds tracked by Wall St. Rank held Utah Medical Products as of Q4 2019.

Based on Fieldpoint Private Securities's 13F filing for Q4 2019, filed 10 Feb 2020.